| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0096 | 0.8 |